COVID-19 and Influenza
Conditions
Interventions
None listed
Sponsors
Hakujikai Healthcare Foundation, Hakujikai Memorial Hospital
Ichikawa children'
s clinic
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who fall under any of the following selection criteria 1 to 4, fulfill the following selection criterion 4 and do not fall under all of the exclusion criteria will be selected as study subjects 1 Patients who fulfill "Table 3-1: Prerequisites for Suspected Patients" in the MHLW Manual for Covid-19 Diagnosis and Treatment, ver. 8 2 Patient to whom a definite diagnosis of Covid-19 was made 3 Patient who is suspected of a respiratory infection caused by such other viruses including influenza virus than novel coronavirus. 4 Patient who is able to understand the explanation about this study and gives informed consent regarding the explanatory documents at his/her own will or at the will of his/her legal representative.
Exclusion criteria
Exclusion criteria: * Patients whose participation in this study is considered inappropriate by the physician involved * Patients who reject to participate in this study by themselves or through their legal representatives
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percent agreement between the study products and the control method | — |
Secondary
| Measure | Time frame |
|---|---|
| Percent agreement based on SARS-CoV-2 RNA copies per test | — |
Countries
Japan
Contacts
Public ContactShusaku Tozaka
Nippon Becton Dickinson Co., Ltd. Medical affairs
Outcome results
None listed